LD-2 disclosure · 2nd Quarter - Amendment
SAGE THERAPEUTICS
Expenses$284Kself-filed spend
Client
- Location
- Massachusetts · United States of America
Registrant
- Description
- Pharmaceutical manufacturing
- Location
- Cambridge, Massachusetts, United States of America
Lobbying activities
2 issuesHealth Issues
Mental Health Innovation at large substances - Cares Act Telehealth and controlled substance prescribing habits for serious mental illness Extension of Public Health Emergency Act for telehealth Senate drug pricing reforms under Medicare Part D TRIPS Waiver
LobbyistsVANESSA PROCTER · JULIE GARNER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Senate drug pricing provisions and Medicare Part D reforms in Reconciliation language Telehealth Medicare Physician Reimbursement Telemental Health Care Access Act of 2021 to remove barriers to telemental health services for Medicare beneficiaries.
LobbyistsVANESSA PROCTER · JULIE GARNER
TargetedSENATE · HOUSE OF REPRESENTATIVES